• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Cash Cows Are Cranking Up the Dividends


Nearly 140 S&P 500 companies raised their dividends or introduced new ones this year. Experts now believe some of these cash cows may declare a special dividend soon to sidestep a potential hike in the dividends tax next year. A look at some solid high-yielding stocks.

With the Great Recession slowly fading, companies are suddenly fat with cash. Non-financial companies in the Standard & Poor’s 500-stock index are sitting on a record $837 billion in cash as of April 1, up from $665 billion the previous year. As a result, about 135 companies in the S&P 500 have increased their dividends, or introduced new ones this year.

With stocks in an up-and-down trading pattern, many investment analysts say dividends can be a good way to lock in an attractive investment yield, especially when compared to the paltry interest rates being paid on traditional safe havens such as high-yielding savings accounts, CDs, and money market funds.

A listing of solid large-cap companies with dividend yields above 4 percent shows that many are in the pharmaceutical business: GlaxoSmithKline PLC (NYSE: GSK); AstraZeneca PLC (NYSE: AZN), Eli Lilly & Co. (NYSE: LLY), and Bristol-Myers Squibb Co. (NYSE: BMY) all are paying dividends in the 4.9% to 5.7% range. Other big companies on the list include AT&T Inc. (NYSE: T) and Unilever N.V. (NYSE: UN).

This free stock screener finds companies with dividend yields of at least 3 percent that haven't cut their dividend in the past five years. (Click the “Morningstar Screens” button, and select “Solid High-Yield Stocks” from the drop-down menu.) The list doesn’t include distressed companies, which are least likely to maintain their dividend in the future. Among its healthcare picks: Abbot Laboratories (NYSE: ABT), Johnson & Johnson (NYSE: JNJ) and Meridian Bioscience Inc. (NASDAQ: VIVO).

Every silver lining comes with a cloud, however. Tax experts warn that the income tax on dividends is likely to be heading higher when the Bush tax cuts expire at the end of the year. Making the issue even iffier is that no one can predict how high tax rates will go. The current tax on dividends is capped at 15 percent, but that top rate may go as high as 39.6 percent next year, depending on what Congress chooses to do. Some market observers are even considering the possibility that some cash-rich companies may declare a special dividend before the end of the year to sidestep the higher tax.

Investment counselors caution that looking for the fattest dividend yields can be risky, since many companies can’t keep up that kind of payout and end up cutting the dividend or eliminating it. Look instead for solid companies that have a long history of paying out dividends.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice